BioNTech names KPMG as independent auditor for FY2027
Bitget2026/09/18 20:10- BioNTech named KPMG as independent auditor for the financial year ending Dec. 31, 2027, pending shareholder election at its AGM.
- The audit committee ran a competitive tender process, then recommended KPMG; the supervisory board will put the appointment to shareholders.
- The company is not subject to mandatory auditor rotation, yet opted to reassess its external audit arrangements as a governance measure.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AstraZeneca (AZN.US) invests in Summit (SMMT.US), gaining positive outlooks from JPMorgan and Citi: Cancer drug strategy awaits validation
Analysts from JPMorgan and Citi have welcomed the deal between AstraZeneca and Summit Therapeutics, stating that it aligns with AstraZeneca's cancer strategy.
The United States relaxes fuel standards, significantly reducing technology costs for automakers: General Motors (GM.US) is expected to save 20.4 billion dollars, and the price per vehicle may drop by nearly 1,300 dollars.
The United States has relaxed fuel economy standards, allowing automakers to save $60.6 billions in technology costs by 2031, with the cost per vehicle expected to decrease by $1,289.
BUZZ-AAR shares rise as first-quarter results beat expectations
Crypto prices
More
